Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rentian Feng

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Molecular Cancer Therapeutics|June 21, 2008
KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signalingRentian Feng, Huihui Ma, Christian A Hassig, et al.
Journal of Alzheimer'S Disease : JAD|February 4, 2017
Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's DiseaseLin Li, Shaofeng Xu, Lifei Liu, et al.
Journal of Medicinal Chemistry|February 15, 2013
Novel triaryl sulfonamide derivatives as selective cannabinoid receptor 2 inverse agonists and osteoclast inhibitors: discovery, optimization, and biological evaluationPeng Yang, Liping Wang, Rentian Feng, et al.
The Journal of Clinical Investigation|April 5, 2016
Multiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic diseaseJing Fu, Shirong Li, Rentian Feng, et al.
Journal of Medicinal Chemistry|October 18, 2012
Lead discovery, chemistry optimization, and biological evaluation studies of novel biamide derivatives as CB2 receptor inverse agonists and osteoclast inhibitorsPeng Yang, Kyaw-Zeyar Myint, Qin Tong, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Molecular Cancer Therapeutics|June 21, 2008
KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signalingRentian Feng, Huihui Ma, Christian A Hassig, et al.
Journal of Alzheimer'S Disease : JAD|February 4, 2017
Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's DiseaseLin Li, Shaofeng Xu, Lifei Liu, et al.
Journal of Medicinal Chemistry|February 15, 2013
Novel triaryl sulfonamide derivatives as selective cannabinoid receptor 2 inverse agonists and osteoclast inhibitors: discovery, optimization, and biological evaluationPeng Yang, Liping Wang, Rentian Feng, et al.
The Journal of Clinical Investigation|April 5, 2016
Multiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic diseaseJing Fu, Shirong Li, Rentian Feng, et al.
Journal of Medicinal Chemistry|October 18, 2012
Lead discovery, chemistry optimization, and biological evaluation studies of novel biamide derivatives as CB2 receptor inverse agonists and osteoclast inhibitorsPeng Yang, Kyaw-Zeyar Myint, Qin Tong, et al.
Pageof 3